TickerGuard
Buy Day today: Neutral (56) Mixed market breadth · no major macro event
OMER

Omeros Corporation

Healthcare · Biotechnology

20.10$ -0.2% vs. previous close Closing price · As of: Sep 25, 2026

Statements

Income Statement

Omeros Corporation (OMER) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Revenue" came in at 0.0 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Income Statement OMER
Line item 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
– 0.2 1.9 1.2 1.4 2.1 4.5 6.0 1.6 0.5 14 42 65 30 112 74 91 0.0 0.0 0.0 0.0
– – 26 25 22 31 31 0.0 18 27 1.0 1.4 1.1 0.5 2.7 1.6 1.4 1.0 70 1.0 –
– 0.2 1.9 1.2 1.4 2.1 4.5 6.0 -17 -26 12 40 64 29 109 -1.6 -1.4 -1.0 -70 -1.0 –
5.8 21 16 18 17 23 24 32 36 48 48 51 56 90 110 108 119 113 115 120 81
– 3.6 10 7.8 5.3 8.7 8.2 11 16 23 34 43 52 49 65 73 55 51 50 50 42
7.7 24 26 26 22 32 32 43 52 71 84 94 108 142 173 155 172 163 165 169 123
-7.7 -24 -24 -25 -21 -30 -27 -37 -51 -70 -71 -54 -44 -112 -63 -157 -174 -163 -165 -169 -123
– 0.1 0.2 0.3 2.2 1.5 1.9 1.7 2.4 3.5 3.6 7.8 11 16 23 27 20 23 31 25 1.0
-7.4 -23 -23 -24 -19 -28 -27 -38 -40 -74 -75 -67 -53 -140 -84 -196 -192 -182 -175 -183 -2.8
– 0.3 0.0 0.7 0.3 -0.9 1.1 1.5 2.9 2.9 4.4 8.5 12 -13 22 -23 -366 -211 -57 26 2.0
-7.4 -23 -23 -24 -21 -29 -29 -38 -40 -74 -75 -67 -53 -127 -84 -138 -111 47 -118 -157 -3.4
-7.4 -22 -23 -24 -18 -27 -26 -36 -37 -70 -71 -59 -42 -122 -60 -168 -170 -158 -143 -157 -1.8

Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?